Due to the size of the Brazilian market for aesthetic and therapeutic products, Pharmaesthetics Group S.A. decided to build its first manufacturing health products site, medicines and biological medicines laboratory in the city of Pinhais, in the state of Paraná, Brazil.

Brazil is amongst the 3 (three) largest markets for the aesthetic products industry. That is why the company decided to open its first production site for the latest generation of reticulated hyaluronic acid and botulinum toxin type A in Brazil, with cutting-edge products and visionary leadership.